Colon cancer is the 3rd most common cancer in the United States. Unfortunately, most patients present with Stage III or IV disease and disease recurrence is high despite advanced in systemic therapies. Despite evidence that gadoxetic acid-enhanced MRI is superior for the detection and diagnosis of colon cancer liver metastases, computed tomography remains the recommended staging and surveillance modality. The purpose of this abstract is to synthesize and analyze the evidence regarding the accuracy of liver MRI to stage and surveil CCLM, and to identify knowledge gaps to inform future research on staging and surveillance imaging for CCLM.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords